1) Cathinone hydrochloride
盐酸卡西酮
2) Ondansetron hydrochloride
盐酸恩丹西酮
1.
Determination the Drug Content of Ondansetron Hydrochloride-loaded Poly (lactide-co-glycolide) Micro-spheres by Ultraviolet Spectrophotometry;
盐酸恩丹西酮乳酸羟基乙酸共聚物微球中药物的含量测定
2.
Preparation of dry-coated sustained-release Ondansetron hydrochloride Tablets;
盐酸恩丹西酮包芯缓释片的研制
3.
METHODS:Ondansetron hydrochloride sustained release capsule was prepared and its release rate was determined,and its releasing mechanism and the influence factors were studied.
目的:制备盐酸恩丹西酮缓释胶囊并建立其质量控制方法。
3) ondansetron
盐酸恩丹西酮
1.
Methods Seventy-five patients undergoing elective gynecologic laparoscopy with general anesthesia were divided randomly into three groups: propofol group (group P), isoflurane + ondansetron group (group I+O) and isoflurane group (group I).
方法择期妇科腹腔镜手术患者75例,随机分为异丙酚组(P组)、异氟醚+盐酸恩丹西酮组(I+O组)和异氟醚组(I组,对照组),每组25例。
2.
OBJECTIVE To establish a HPCE chiral separation method for ondansetron enantiomers,and to investigate the stereoselective pharmacokinetics of the two enantiomers in rats with computational chemistry to determine the seguence of the two enatiomers in HPCE.
目的建立血浆中盐酸恩丹西酮(OND)的高效毛细管电泳手性分离分析方法,并运用该法对盐酸恩丹西酮两对映体在大鼠体内的立体选择性药动学进行研究,同时使用计算机辅助分子模型设计及计算的方法确定两对映体的毛细管电泳峰位。
4) zipraside
盐酸齐拉西酮片
1.
Objective To evaluate the clinical effect and safety of zipraside and haloperidol in the treatment of schizophrenia.
方法选择住院患者60例,采用随机双盲法将患者分配至治疗组(30例,口服盐酸齐拉西酮片)与对照组(30例,口服氟哌啶醇片),疗程6周,临床疗效用精神分裂症阳性与阴性症状评定量表(PANSS)评定,安全性用不良反应量表(TESS)评定。
5) Ondansetron HCI
盐酸奥旦西酮
补充资料：盐酸恩丹西酮
分子式：C18H20ClN3O
分子量：329.83
CAS号：103639-04-9
性质：暂无
制备方法：暂无
用途：止吐药，用于化疗、放疗及手术引起的呕吐。
分子量：329.83
CAS号：103639-04-9
性质：暂无
制备方法：暂无
用途：止吐药，用于化疗、放疗及手术引起的呕吐。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条